KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,065,176 | -19.9% | 2,287,146 | +7.0% | 0.00% | – |
| Q2 2023 | $3,825,398 | -44.5% | 2,137,094 | +20.6% | 0.00% | -100.0% |
| Q1 2023 | $6,892,041 | +147102.9% | 1,771,733 | +28.7% | 0.00% | 0.0% |
| Q4 2022 | $4,682 | -99.9% | 1,377,128 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $7,264,000 | +21.5% | 1,330,435 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $5,981,000 | -39.3% | 1,326,319 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $9,860,000 | +6.3% | 1,337,888 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $9,276,000 | +13.3% | 1,442,731 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $8,189,000 | -33.6% | 1,407,157 | +17.7% | 0.00% | -50.0% |
| Q2 2021 | $12,335,000 | +2.3% | 1,195,278 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $12,063,000 | -25.1% | 1,146,715 | +10.3% | 0.00% | -33.3% |
| Q4 2020 | $16,096,000 | +4.5% | 1,039,847 | -1.5% | 0.00% | 0.0% |
| Q3 2020 | $15,407,000 | -21.2% | 1,055,335 | +2.2% | 0.00% | -25.0% |
| Q2 2020 | $19,557,000 | +9.1% | 1,032,592 | +10.6% | 0.00% | -20.0% |
| Q1 2020 | $17,928,000 | -43.5% | 933,327 | -43.6% | 0.01% | +66.7% |
| Q4 2019 | $31,706,000 | +318.3% | 1,653,944 | +109.9% | 0.00% | +50.0% |
| Q3 2019 | $7,579,000 | +64.0% | 787,879 | +2.1% | 0.00% | +100.0% |
| Q2 2019 | $4,622,000 | +34.9% | 771,703 | +31.5% | 0.00% | 0.0% |
| Q1 2019 | $3,426,000 | -67.2% | 586,659 | -47.4% | 0.00% | -50.0% |
| Q4 2018 | $10,454,000 | +15.5% | 1,115,854 | +109.9% | 0.00% | -33.3% |
| Q3 2018 | $9,052,000 | +3.3% | 531,569 | +3.1% | 0.00% | 0.0% |
| Q2 2018 | $8,759,000 | +103.1% | 515,596 | +60.5% | 0.00% | +200.0% |
| Q1 2018 | $4,312,000 | +60.1% | 321,323 | +14.5% | 0.00% | 0.0% |
| Q4 2017 | $2,693,000 | -7.5% | 280,610 | +5.8% | 0.00% | 0.0% |
| Q3 2017 | $2,911,000 | +23.6% | 265,121 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $2,356,000 | +8.7% | 260,419 | +54.3% | 0.00% | 0.0% |
| Q1 2017 | $2,167,000 | +47.3% | 168,770 | +7.8% | 0.00% | 0.0% |
| Q4 2016 | $1,471,000 | +3.2% | 156,493 | +6.8% | 0.00% | 0.0% |
| Q3 2016 | $1,425,000 | +48.1% | 146,487 | +2.1% | 0.00% | 0.0% |
| Q2 2016 | $962,000 | -22.2% | 143,471 | +3.4% | 0.00% | 0.0% |
| Q1 2016 | $1,237,000 | -32.6% | 138,717 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $1,836,000 | +28.0% | 138,644 | +1.7% | 0.00% | 0.0% |
| Q3 2015 | $1,434,000 | -60.1% | 136,269 | +3.2% | 0.00% | -50.0% |
| Q2 2015 | $3,592,000 | -4.7% | 132,030 | +7.2% | 0.00% | 0.0% |
| Q1 2015 | $3,768,000 | +30.2% | 123,113 | +59.2% | 0.00% | 0.0% |
| Q4 2014 | $2,893,000 | +6.6% | 77,314 | -0.4% | 0.00% | 0.0% |
| Q3 2014 | $2,713,000 | +20.9% | 77,658 | +61.0% | 0.00% | +100.0% |
| Q2 2014 | $2,244,000 | +62.8% | 48,220 | +8.1% | 0.00% | 0.0% |
| Q1 2014 | $1,378,000 | +69.7% | 44,621 | +25.9% | 0.00% | 0.0% |
| Q4 2013 | $812,000 | – | 35,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |